Publications by authors named "Paula M O' Shea"

Introduction: Capillary blood collection, a technique traditionally used in diabetes care, shows promise for many applications including pregnancy monitoring. Serial measurement of serum human Chorionic Gonadotrophin (hCG) is frequently necessary for managing early pregnancy, including molar pregnancy, requiring multiple visits to a maternity hospital for blood collection by venepuncture. This proof-of-concept study aimed to assess the clinical performance and user acceptability of capillary blood samples collected remotely, as an alternative to venous blood for hCG measurement.

View Article and Find Full Text PDF

Aims: Diagnosis of hydatidiform mole or molar pregnancy based on morphology alone can be challenging, particularly in early gestation, necessitating the use of ancillary techniques for accurate diagnosis. We sought to adapt the VENTANA dual-colour dual-hapten in-situ hybridisation (D-DISH) assay by using the internal chromosome 17 enumeration probe to determine ploidy status.

Methods: We selected 25 products of conception, consisting of molar and non-molar cases, to validate the D-DISH assay.

View Article and Find Full Text PDF

Context: It is not clear if the risk of abnormal glucose tolerance (AGT) is attenuated in the long-term in women diagnosed with gestational diabetes (GDM) using the World Health Organization (WHO) 2013 criteria and who have received appropriate treatment during pregnancy.

Objective: We aimed to assess the long-term prevalence of AGT and other cardiovascular disease (CVD) risk factors in this cohort.

Methods: A retrospective cohort follow-up study was conducted of 37 and 107 women diagnosed with and without GDM respectively using the WHO 2013 criteria between June 2010 and December 2010.

View Article and Find Full Text PDF

Objective: Identify the impact of COVID-19 lockdown restrictions on the vitamin D status of individuals in the west of Ireland.

Design: Cross-sectional study.

Setting: Adults who had wintertime serum 25(OH)D analysis completed in Galway University Hospital.

View Article and Find Full Text PDF

Background: Adopting the WHO protocol for glucose analysis is arguably impractical in the routine clinical setting. Deviations may develop due to a lack of understanding regarding the impact of glycolysis on the accuracy of results.

Aim: We sought to assess the stability of glucose in two different blood collection tubes (BCT), BD Vacutainer® FX 'Fl-Ox' and Greiner Vacuette® FC-Mix 'FC-Mix' stored at room temperature (RT:18-22°C) and 4°C over 8.

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the potential of plasma glycated CD59 (pGCD59) as a biomarker to predict postpartum glucose intolerance in women who had gestational diabetes.
  • Postpartum pGCD59 levels were significantly higher in women with glucose intolerance compared to those with normal levels, and it showed good predictive ability with an area under the curve (AUC) of 0.80.
  • However, while pGCD59 may help identify women who do not need traditional glucose intolerance screening, fasting plasma glucose tests demonstrated even better diagnostic accuracy.
View Article and Find Full Text PDF

Primary aldosteronism is the most common cause of secondary hypertension. The first-line treatment adrenalectomy resects adrenal nodules and adjacent normal tissue, limiting suitability to those who present with unilateral disease. Use of thermal ablation represents an emerging approach as a possible minimally invasive therapy for unilateral and bilateral disease, to target and disrupt hypersecreting aldosterone-producing adenomas, while preserving adjacent normal adrenal cortex.

View Article and Find Full Text PDF

Aim: Even though most pregnancies are uneventful, occasionally complications do occur. Gestational diabetes is linked to an increased risk of adverse pregnancy outcomes. Early identification of women at risk of experiencing adverse outcomes, ideally through a single blood test, would facilitate early intervention.

View Article and Find Full Text PDF
Article Synopsis
  • This study analyzed how pregnancy affects lab test results, aiming to create trimester-specific reference intervals (RIs) for healthy white European women during their pregnancies.
  • A total of 124 healthy participants were included, with strict inclusion criteria ensuring they were without previous health issues and at a normal BMI.
  • The results will help healthcare providers interpret lab tests more accurately throughout the different stages of pregnancy, improving patient care based on trimester-specific data.
View Article and Find Full Text PDF
Article Synopsis
  • Neonatal hypoglycaemia (NH) is a common issue in infants of mothers with gestational diabetes, and this study explores the link between maternal early pregnancy levels of plasma glycated CD59 (pGCD59) and NH.
  • The research involved 399 pregnant women, examining their pGCD59 levels during a glucose tolerance test, and found that higher maternal pGCD59 levels correlated with an increased risk of NH in their infants.
  • The findings suggest that while pGCD59 is associated with NH, its predictive value diminishes when considering maternal BMI, implying that pGCD59 alone may not be a strong enough predictor for NH in this population.
View Article and Find Full Text PDF

Aims: To evaluate the ability of first trimester plasma glycated CD59 (pGCD59) to predict gestational diabetes mellitus (GDM) at 24-28 weeks of gestation.

Methods: Prospectively, in 378 pregnant women, GDM was diagnosed using the one step 2 h 75 g oral glucose tolerance test adjudicated by the World Health Organisation (WHO) 2013 criteria. The ability of pGCD59 to predict GDM was assessed using receiver operating characteristic (ROC) curves adjusted for maternal age, body mass index (BMI), maternal ethnicity, parity, previous GDM, family history of diabetes mellitus and week of gestation at time of pGCD59 sampling.

View Article and Find Full Text PDF

The aim of this study was to evaluate the ability of second trimester plasma glycated CD59 (pGCD59), a novel biomarker, to predict the results of the 2 h 75 g oral glucose tolerance test at 24−28 weeks of gestation, employing the 2013 World Health Organisation criteria. This was a prospective study of 378 pregnant women. The ability of pGCD59 to predict gestational diabetes (GDM) was assessed using adjusted ROC curves for maternal age, BMI, maternal ethnicity, parity, previous GDM, and family history of diabetes.

View Article and Find Full Text PDF

Aims: The purpose of this study was to assess the clinical performance and user acceptance of capillary blood samples prepared remotely using the MiniCollect® capillary blood collection device as an alternative to blood collection by venepuncture for glycated haemoglobin (HbA ) analysis.

Methods: Following written informed consent, a cross-sectional study was conducted in individuals aged ≥18 years with any type of diabetes who routinely self-monitor their blood glucose. Eligible participants recruited whilst attending their routine clinical appointments were required to provide a venous blood sample, prepare a capillary blood sample at home (remotely) and complete a bespoke questionnaire.

View Article and Find Full Text PDF
Article Synopsis
  • A study investigated the effects of a 24-week low energy liquid diet (LELD) on leptin and adiponectin levels in patients with severe obesity, measuring the leptin:adiponectin ratio (LAR) as an indicator of insulin resistance and cardiovascular risk.
  • Out of 120 participants, 52 completed the diet, resulting in significant weight loss, with average weight dropping from 148.2 kg to 125.4 kg and improvements in HbA1c for those with type 2 diabetes.
  • The study found that LAR decreased significantly, indicating reduced insulin resistance, and that the degree of weight loss was directly linked to the reduction in LAR, particularly in patients with type 2 diabetes
View Article and Find Full Text PDF

While a low vitamin D state has been associated with an increased risk of infection by SARS-CoV-2 in addition to an increased severity of COVID-19 disease, a causal role is not yet established. Here, we review the evidence relating to i) vitamin D and its role in SARS-CoV-2 infection and COVID-19 disease ii) the vitamin D status in the Irish adult population iii) the use of supplemental vitamin D to treat a deficient status and iv) the application of the Bradford-Hill causation criteria. We conclude that reverse causality probably makes a minimal contribution to the presence of low vitamin D states in the setting of COVID-19.

View Article and Find Full Text PDF

Aim: Many challenges exist in determining true rates of adherence to antihypertensive medications among individuals in a clinic setting. For the first time, we aimed to compare patient-reported antihypertensive adherence with objective evidence using mass spectrometry spot urinalysis in a tertiary referral clinic setting.

Methods: A prospective observational single-centre cohort study was performed in a tertiary referral hypertension clinic, encompassing antihypertensive initiation and persistence.

View Article and Find Full Text PDF

Introduction: Diabetes mellitus is the most common metabolic complication of pregnancy and its prevalence worldwide is rising. The number of randomised controlled trials (RCTs) being conducted in people with diabetes is also increasing. Many studies preferentially publish findings on clinical endpoints and do not report patient-reported outcomes (PROs).

View Article and Find Full Text PDF

Summary: A 32-year-old Caucasian male presented to the emergency department with a one-day history of acute severe bilateral lower limb weakness, three days after competing in a bodybuilding competition. He consumed large quantities of carbohydrate-rich foods following the competition. His past medical history was significant for anxiety, and family history was non-contributory.

View Article and Find Full Text PDF

Cushing's syndrome is a rare disorder of cortisol excess and is associated with significant morbidity and mortality. Hypercalcaemia due to hyperparathyroidism is a common condition; however, in 10% of young patients, it is associated with other endocrinopathies and occurs due to a genetic variant [e.g.

View Article and Find Full Text PDF

Introduction: This study aimed to determine the prevalence of diabetic kidney disease (DKD) and rapid renal function decline and to identify indices associated with this decline among adults attending a diabetes center in Northern Europe.

Research Design And Methods: This is a retrospective cohort study of 4606 patients who attended a diabetes center in Ireland between June 2012 and December 2016. Definition/staging of chronic kidney disease used the Kidney Disease: Improving Global Outcomes (KDIGO) 2012 classification based on data from the most recently attended appointment.

View Article and Find Full Text PDF

Gestational diabetes (GDM), defined as hyperglycemia with onset or initial recognition during pregnancy, has a rising prevalence paralleling the rise in type 2 diabetes (T2DM) and obesity. GDM is associated with short-term and long-term consequences for both mother and child. Therefore, it is crucial we efficiently identify all cases and initiate early treatment, reducing fetal exposure to hyperglycemia and reducing GDM-related adverse pregnancy outcomes.

View Article and Find Full Text PDF

Background: Hypernatraemia arises commonly in acute general medical admissions. Affected patients have a guarded prognosis with high rates of morbidity and mortality. Age-related physiology and physical/cognitive barriers to accessing water predispose older patients to developing hypernatraemia.

View Article and Find Full Text PDF

Background: Early recognition of sepsis and prompt treatment improves patient outcome. C-reactive protein is a sensitive marker for tissue damage and inflammation, but procalcitonin has greater specificity for bacterial infection. Limited research exists regarding the use of C-reactive protein and procalcitonin at term pregnancy and the immediate postpartum period.

View Article and Find Full Text PDF

Background/objectives: The Institute of Medicine (IOM) recommends gestational weight gain (GWG) of 5-9 kg in women with a body mass index (BMI) ≥ 30 kg/m. Debate continues as to whether GWG less than that recommended is safe in women with gestational diabetes mellitus (GDM). The study objective was to examine maternal and infant outcomes for obese women with GDM who lost weight or gained 0-5 kg during pregnancy.

View Article and Find Full Text PDF